The Discounted Cash Flow (DCF) valuation of Horizon Therapeutics PLC (HZNP) is 100.24 USD. With the latest stock price at 116.30 USD, the upside of Horizon Therapeutics PLC based on DCF is -13.8%.
Based on the latest price of 116.30 USD and our DCF valuation, Horizon Therapeutics PLC (HZNP) is a sell. selling HZNP stocks now will result in a potential gain of 13.8%.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.1% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 64.18 - 246.75 | 100.24 |
| Upside | -44.8% - 112.2% | -13.8% |